(A) Persistence of non-DTA mutations is associated with a higher risk of relapse. (B) Persistence of DTA-only mutations in remission is not associated with risk of relapse. (C) Persistence of DTA and non-DTA) mutations in remission is associated with a higher risk of relapse. MRD, minimal residual disease.

(A) Persistence of non-DTA mutations is associated with a higher risk of relapse. (B) Persistence of DTA-only mutations in remission is not associated with risk of relapse. (C) Persistence of DTA and non-DTA) mutations in remission is associated with a higher risk of relapse. MRD, minimal residual disease.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal